Docu-Proof, Digital-Page, ScanTVS, BarProof selected by Pfizer to provide end-to-end inspection across their entire packaging workflow

Montreal, CANADA -? Global Vision, the industry leader in the development of automated proofreading solutions, today announced that it has been selected by Pfizer for worldwide deployment as its proofreading technology solution provider. This deployment enables Pfizer to drive consistency, reduce costs and subjectivity for artwork and labeling verification throughout the entire packaging workflow process.

With a goal to identify, recommend and implement a global harmonized proofreading technology, a project team was formed within Pfizer to evaluate different technologies that could enhance packaging quality. Global Vision?s best-in-class text, artwork, print & barcode technologies were selected by Pfizer to provide complete inspection end-to-end. 

Docu-Proof - text verification and comparison for Regulatory Affairs

Digital-Page - artwork & proof revision comparator

ScanTVS - print inspection system

BarProof - barcode decoder & verification

?Protecting your brands integrity is the lifeblood of a company?s continued success,? explained Reuben Malz, President of Global Vision. ?As a global pharmaceutical leader, Pfizer?s decision to deploy Global Vision?s suite of inspection solutions will help ensure that the high quality control standards, synonymous with Pfizer, are maintained.?